Melanoma trials in Estonia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Neoadjuvant Darovasertib in Primary Uveal Melanoma

  Where

  Tallinn

  Age

  18 years and over

  People

  520 worldwide

  Run by

  IDEAYA Biosciences

  See details and how to joinNCT07015190 · EU 2025-522387-32-00